Mirum Pharmaceuticals Cash from Financing (TTM) Insights

Mirum Pharmaceuticals Inc (MIRM)

25.84 +0.24 (+0.94%) USD | NASDAQ | May 03, 16:00

25.82 -0.02 (-0.08%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	336.60M
September 30, 2023	334.49M
June 30, 2023	213.43M
March 31, 2023	103.97M
December 31, 2022	109.09M
September 30, 2022	110.03M
June 30, 2022	24.31M
March 31, 2022	84.98M
December 31, 2021	73.47M

Date	Value
September 30, 2021	207.36M
June 30, 2021	209.11M
March 31, 2021	143.22M
December 31, 2020	181.29M
September 30, 2020	46.78M
June 30, 2020	113.10M
March 31, 2020	171.84M
December 31, 2019	127.18M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

24.31M

Minimum

Jun 2022

336.60M

Maximum

Dec 2023

152.37M

Average

127.18M

Median

Dec 2019

Cash from Financing (TTM) Benchmarks